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Enterohemorrhagic Escherichia coli (EHEC) and enteropathogenic E. coli (EPEC) are diar-
rheagenic pathotypes of E. coli that cause gastrointestinal disease with the potential
for life-threatening sequelae. While certain EHEC and EPEC virulence mechanisms have
been extensively studied, the factors that mediate host colonization remain to be properly
defined. Previously, we identified four genes (ehaA, ehaB, ehaC, and ehaD) from the proto-
typic EHEC strain EDL933 that encode for proteins that belong to the autotransporter (AT)
family. Here we have examined the prevalence of these genes, as well as several other
AT-encoding genes, in a collection of EHEC and EPEC strains. We show that the comple-
ment of AT-encoding genes in EHEC and EPEC strains is variable, with some AT-encoding
genes being highly prevalent. One previously uncharacterized AT-encoding gene, which we
have termed ehaJ, was identified in 12/44 (27%) of EHEC and 2/20 (10%) of EPEC strains.
The ehaJ gene lies immediately adjacent to a gene encoding a putative glycosyltransferase
(referred to as egtA). Western blot analysis using an EhaJ-specific antibody indicated that
EhaJ is glycosylated by EgtA. Expression of EhaJ in a recombinant E. coli strain, revealed
EhaJ is located at the cell surface and in the presence of the egtA glycosyltransferase
gene mediates strong biofilm formation in microtiter plate and flow cell assays. EhaJ also
mediated adherence to a range of extracellular matrix proteins, however this occurred
independent of glycosylation. We also demonstrate that EhaJ is expressed in a wild-type
EPEC strain following in vitro growth. However, deletion of ehaJ did not significantly alter
its adherence or biofilm properties. In summary, EhaJ is a new glycosylated AT protein
from EPEC and EHEC. Further studies are required to elucidate the function of EhaJ in
colonization and virulence.
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INTRODUCTION
Shiga toxin-producing Escherichia coli (STEC) and enteropath-
ogenic E. coli (EPEC) are pathotypes of E. coli responsible for
different pathologies in humans. EPEC are associated with small
intestinal enteritis, and are a major cause of childhood diarrhea
(Nataro and Kaper, 1998). STEC may also be associated with
diarrhea, with some strains inducing more severe forms of enteri-
tis such as hemorrhagic colitis, or extraintestinal disease such as
hemolytic uremic syndrome (Karch et al., 2005). Such enhanced
virulence STEC strains are referred to as enterohemorrhagic E. coli
(EHEC). Both pathogens and their associated diseases are preva-
lent globally, with EPEC being a more significant cause of mor-
bidity and mortality in developing countries (Nataro and Kaper,
1998; Bardiau et al., 2010). EPEC are generally considered to
be communicable pathogens, being transmitted from human to
human via the fecal-oral route. STEC (and therefore EHEC) are
recognized zoonotic pathogens, with ruminant livestock being the
principal host (Nataro and Kaper, 1998; Gyles, 2007). Food-borne
transmission is important in the epidemiology of both EPEC and
EHEC.
The molecular mechanisms associated with the colonization of
human and animal hosts by EHEC and EPEC are not fully under-
stood. The locus for enterocyte effacement (LEE) encodes a type
three secretion system that is found in representative strains of
both EHEC and EPEC. Whilst there are component protein and
tissue tropism differences between LEE products (particularly for
intimin, the key effector) for EPEC and EHEC, this mechanism
appears functionally analogous in both pathogens in contributing
to host cell attachment (Bardiau et al., 2010). In EHEC, several
additional adhesins including Iha (Tarr et al., 2000), long polar
fimbriae (Torres et al., 2002), curli (Uhlich et al., 2001), F9 fim-
briae (Dziva et al., 2004; Low et al., 2006), Saa (Paton et al., 2001),
and Efa1 (Nicholls et al., 2000) have been described. The roles and
mechanisms of these adhesins (individually and/or in concert)
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in mediating host colonization remain to be fully elucidated. An
improved understanding of EPEC and EHEC mucosal adher-
ence may lead to development of interventions that will disrupt
host colonization, be it colonization of humans as a prelude to
pathogenesis, or colonization of livestock leading to carriage and
maintenance of EHEC that can be subsequently transmitted to
humans.
Several cell-surface proteins from the typeV secreted autotrans-
porter (AT) class have been characterized fromEHEC.AT proteins
are common to many Gram-negative pathogens and have diverse
functions ranging from cell-associated adhesins to secreted tox-
ins. All AT proteins have several common features: an N-terminal
signal sequence, a passenger (α) domain that often encodes a viru-
lence function and is either anchored to the cell surface or released
into the externalmilieu and a translocation (β) domain that resides
in the outer membrane (Jose et al., 1995; Henderson et al., 1998).
Three broad categories of AT proteins have been defined in the
literature based on domain-architecture: the serine protease AT
proteins of Enterobacteriaceae (SPATEs), the AIDA-I type AT pro-
teins and the trimeric AT adhesins (TAAs; Henderson et al., 2004).
Among the AIDA-I group, the Ag43 protein (found in most E. coli
strains), the TibA adhesin (associated with some enterotoxigenic
E. coli) and the AIDA adhesin (associated with some diarrhea-
causing E. coli) represent well characterized AT proteins that
mediate aggregation, biofilm formation and can be glycosylated
(Klemm et al., 2006). We previously described the identification
and characterization of four AT proteins from E. coli EDL933 that
belong to theAIDA-I group (Wells et al., 2008, 2009). Here we have
extended this analysis to include a larger collection of EHEC and
EPEC strains and also examined the prevalence of seven recently
identified AT-encoding genes, two from the AIDA-I group (i.e.,
groups 6 and 7) and five from the TAA group (i.e., groups 1–5;
Wells et al., 2010). In this study we have examined the relative
prevalence of the various identified AT genes among EPEC and
EHEC strains.Wehave also characterized the functional properties
of a newly recognized AT, namely EhaJ.
MATERIALS AND METHODS
STRAINS AND MEDIA
The EHEC and EPEC strains used to assess the prevalence of AT-
encoding genes were obtained from CSIRO Food and Nutritional
Sciences, Queensland Health Forensic and Scientific Services, and
the New South Wales Department of Primary Industries. EPEC
MS455 is anO27:H6 strain fromour laboratory collection andwas
positive for ehaA, ehaB, ehaC, ehaJ, and a group 4/5 AT-encoding
gene by PCR screening. E. coli MS427 (MG1655flu) and OS56
[green fluorescent protein (GFP)-tagged MG1655flu] have been
described previously (Kjaergaard et al., 2000; Sherlock et al., 2004).
Cells were grown at 37˚C on solid or in liquid Luria–Bertani (LB)
media supplemented with the appropriate antibiotics unless oth-
erwise stated. Where necessary, gene expression was induced with
0.2% arabinose.
DNA MANIPULATIONS AND GENETIC TECHNIQUES
Genomic DNA was extracted from overnight cultures using the
Wizard
®
Genomic DNA Purification Kit (Promega) following the
manufacturer’s procedure for Gram-negative bacteria. Plasmid
DNA was isolated using the QIAprep Spin Miniprep Kit (Qiagen)
following the manufacturer’s instructions. Restriction digests, lig-
ations, and T4 polymerase treatment followed the manufacturer’s
recommendations (New England BioLabs). PCR reactions for
which high fidelity was required were performed using Expand
High Fidelity Polymerase System (Roche) following the manu-
facturer’s recommendations. Taq DNA polymerase (New England
BioLabs) was used for screening PCR reactions. DNA sequencing
was performedby theAustralian EquineGenetics ResearchCentre.
PREVALENCE OF AT-ENCODING GENES
The prevalence of each AT-encoding gene was assessed by PCR
using primers specific to the translocation-encoding domain.
Primers for ehaA, ehaB, ehaC, and ehaD were as previously
described (Wells et al., 2008). Primers for the group 1, 2/3,
4/5, and 6/7 AT-encoding genes were as follows: group 1: 2105
(5′-gggtatggctctcaggtgaa) and 2106 (5′-agcatcagcaacagcatcac);
group 2/3: 2107 (5′-acgyctgracagccagcagc) and 2108 (5′-
gcggtctgctcgttgaagcg); group 4/5: 2109 (5′-caaatkcarmgtctggcgca)
and 2110 (5′-cagacacccgagattcaccg); group 6/7: 2111 (5′-
tgccayhtggtttgccgatg) and 2112 (5′-agayrrcctgtgcctgtggc). Preva-
lence of the ehaJ gene (which belongs to group 6) was assessed
using primers 2442 (5′-aaggcggggaatgcagcgtc) and 2443 (5′-
gcgtcaggctgagcgtgtgt). The groups were combined for initial
screening where sufficient sequence conservation existed.
CONSTRUCTION OF PLASMIDS
The egtA–ehaJ and ehaJ genes were amplified by PCR from
MS455 using primers designed from the available genome
sequence of EPEC strain 2348/69. The following primers were
used: egtA–ehaJ (141, 5′-cgcgctcgagataataaggagctttacagtgagtaataat
and 142, 5′-cggcgaagcttctctgtattttaccaactgt); ehaJ (143, 5′-
cgcgctcgagataataaggactaattcatgaacagaactt and 142). The PCR
products containing egtA–ehaJ and ehaJ, respectively, were
digested withXhoI (forward primer) andHindIII (reverse primer)
and ligated to XhoI–HindIII digested plasmid pBAD/Myc-HisA
to generate plasmids pOMS2 (contains egtA–ehaJ ) and pOMS3
(contains ehaJ ). In both constructs, expression of ehaJ is under
control of the arabinose-inducible araBAD promoter (Guzman
et al., 1995) and a stop codon is included so as to produce the
recombinant protein without any tags introduced by the vector.
The kanamycin cassette from pUC4K (GE Healthcare Life Sci-
ences) was subsequently inserted into the HindIII site of pOMS2
to generate pOMS2-kan and enable its transformation into E. coli
OS56. The pBAD/Myc-HisA vector was similarly manipulated to
produce the negative control plasmid pBAD-kan.
CONSTRUCTION OF AN ehaJ MUTANT IN EPEC STRAIN MS455
The ehaJ gene was deleted from E. coli MS455 using a mod-
ification of the λRed recombinase gene replacement system
(Datsenko andWanner, 2000). The kanamycin cassette was ampli-
fied frompKD4usingprimers 2571 (5′-ggcggatccgtgtaggctggagctg-
cttc) and 2572 (5′-ggcggatcccatatgaatatcctccttag), which include
BamHI recognition sites. Flanking DNA consisting of approx-
imately 500 bp up- and down-stream of ehaJ were amplified
using primer pairs 2562 (5′-gccgctacagcaacgggtgga)/2575 (5′-
ggcggatccgatgtggattccgcctgcgc) and 2576 (5′-ggcggatccacacactgac-
catcaacggc)/2565 (5′-cgcatccagacactgccatct). The PCR products
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were digested with BamHI and the flanking regions ligated with
T4 DNA ligase, PCR amplified, A-tailed and inserted in to the
pGEM-T easy vector (Promega). The resulting plasmid was again
digested with BamHI and the kanamycin cassette was ligated in
between the two flanking regions. The∼2.5 kb construct was then
amplified using the outer most primers (2562 and 2565). This
construct was used to transform MS455(pKD46) by electropora-
tion; transformants were selected by growth on agar containing
kanamycin (50μg/mL) and screened by PCR using primers 2599
(5′-gagcagatattctgcgaata), 2600 (5′-ttgagctttcaggctcgcc), 2601 (5′-
gctaccgagtgctgtgcatc), and 2602 (5′-tgtcggtgtcggcattgacg) in com-
binationwith primers specific for the kanamycin cassette (1287,5′-
ttgcacgcaggttctccg and 1288, 5′-acagctgcgcaaggaacg). The correct
insertion of the kanamycin cassette was confirmed by sequencing
using these sameprimers. This strainwas referred to asMS455ehaJ.
ANTISERUM PRODUCTION AND IMMUNOBLOTTING
A 6× histidine-tagged truncated form of EhaJ was constructed.
Primers 2377 (5′-tacttccaatccaatgcggaatccacatctgaggtgacg) and
2378 (5′-ttatccacttccaatgttaccaggacagtgaagtggtcag) were used to
amplify the predicted passenger-encoding domain,whichwas then
inserted into the pMCSG7 vector by ligation-independent cloning
and maintained in E. coli DH5α. This plasmid was then trans-
ferred to E. coli BL21 for expression of the recombinant protein by
inductionwith 1mMIPTGandpurification byNi-NTASuperflow
columns (Qiagen) under denaturing conditions. Protein purity
was assessed by SDS-PAGE analysis as previously described (Ulett
et al., 2006). Polyclonal anti-EhaJ serum was raised in rabbits by
the Institute of Medical andVeterinary Sciences (South Australia).
For immunoblotting, cell lysates were subjected to SDS-PAGE
and transferred to polyvinylidene difluoride microporous mem-
brane filters as described previously (Ulett et al., 2006). Serum
raised against the passenger subunit of EhaJ was used as primary
serum and the secondary antibody was alkaline phosphatase-
conjugated anti-rabbit immunoglobulin G; 5-bromo-4-chloro-
3-indolylphosphate-nitroblue tetraolium (BCIP/NBT) was used
as the substrate in the detection process. Glycosylation of EhaJ
was demonstrated by staining of SDS-PAGE separated proteins
from whole cell lysates of MS427(pOMS2) with the Glycopro-
file III stain (Sigma-Aldrich) according to the manufacturer’s
recommendations.
ANALYSIS OF BIOFILM FORMATION
Biofilm formation on polystyrene surfaces was assessed in
96-well microtiter plates (Iwaki) essentially as previously
described (Kjaergaard et al., 2000). Briefly, MS427(pOMS2) or
MS427(pOMS3) and MS427(pBAD) were grown for 24 h in glu-
cose M9 minimal medium (containing 0.2% arabinose for induc-
tion of gene expression) at 37˚C, washed to remove unbound cells
and stained with crystal violet. Quantification of bound cells was
assessed by adding acetone–ethanol (20:80) to dissolve the crystal
violet, and the optical density was measured at 595 nm.
Flow chamber experimentswere performed essentially as previ-
ously described (Allsopp et al., 2010) inM9minimalmedia. Briefly,
GFP-tagged strains OS56(pBAD-kan) and OS56(pOMS2-kan)
were allowed to form biofilms on glass surfaces in a multi-channel
flow system that permitted in situ monitoring of community struc-
tures. Flow cells were inoculated withOD600 standardized cultures
grown overnight in M9 medium containing kanamycin. Biofilms
were analyzed over 48 h, with confocal images captured at 16 and
48 h.
MICROSCOPY AND IMAGE ANALYSIS
An anti-EhaJ-specific serum was used for immunofluores-
cence microscopy as previously described (Wells et al., 2008).
Briefly, overnight cultures of MS427(pBAD), MS427(pOMS2),
and MS427(pOMS3) induced with 0.2% arabinose were fixed
and incubated with primary rabbit polyclonal anti-EhaJ serum
followed by incubationwith a secondary goat anti-rabbit IgG anti-
body conjugated to FITC.Microscopic observation of biofilms and
image acquisition were performed on a scanning confocal laser
microscope (LSM510 META, Zeiss) equipped with detectors and
filters for monitoring of GFP. Vertical cross sections through the
biofilms were visualized by using the Zeiss LSM image examiner.
Imageswere further processed for display by using Photoshop soft-
ware (Adobe, Mountain View, CA, USA). For analysis of the flow
cell biofilms, z-stacks were analyzed using COMSTAT software
program (Heydorn et al., 2000).
ECM PROTEIN BINDING ASSAYS
Bacterial binding to MaxGel Human ECM (Sigma-Aldrich) and
extra cellularmatrix (ECM)proteinswasperformed in amicrotiter
plate ELISA assay.Microtiter plates (MaxiSorp;Nunc) were coated
overnight at 4˚Cwith 2μg ofMaxGelHumanECMor individually
with the following ECM proteins (final amount of 2μg/well): col-
lagen type I, type II, type III, type IV, and type V, fibronectin,
fibrinogen, laminin, elastin, heparin sulfate, and BSA (Sigma-
Aldrich). Wells were washed twice with TBS (137mM NaCl,
10mM Tris pH 7.4) and then blocked with TBS-2% skim milk
for 1 h. After being washed with TBS, 200μL of bacterial cell
suspension (standardized to OD600 = 0.1) was added and the
plates were incubated at 37˚C for 2 h. After being washed to
remove non-adherent bacteria, adhered cells were fixed with 4%
paraformaldehyde, washed, and incubated for 1 h with anti-E.
coli serum (Meridian Life Sciences Inc., #B65001R) diluted 1:500
in 0.2% skim milk, 0.05% Tween-20 in TBS, washed and incu-
bated for 1 h with a secondary anti-rabbit horseradish peroxidase
antibody (Sigma-Aldrich; #A6154) diluted 1:1000 in 0.2% skim
milk, 0.05% Tween-20 in TBS. After a final wash adhered bacteria
were detected by adding 150μL of 0.3mg/ml ABTS [2,2-azino-
bis(3-ethylbenzthiazoline-6-sulfonic acid)] (Sigma-Aldrich) in
0.1M citric acid pH 4.3, activated with 1μL/mL 30% hydro-
gen peroxide, and the absorbance was read at 405 nm. Mean
absorbance readings were compared with negative control read-
ings [MS427(pBAD)] using two-sample t -tests within theMinitab
V14 software package (Coventry, UK). P values <0.05 were
considered significant.
RESULTS
PREVALENCE OF AT-ENCODING GENES IN EHEC AND EPEC
The prevalence of selected AT-encoding genes from the AIDA-I
and TAA groups was assessed by PCR screening of EHEC and
EPEC strains from our laboratory collection. For this purpose,
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we employed primers designed to amplify a region within the
conserved translocation-encoding domain of each gene.We found
that a correct sized product was amplified from representative
EHEC and EPEC strains for ehaA, ehaB, ehaC, ehaD, and the group
2, 3, 4, 5, 6, and 7AT-encoding genes (Table 1). In contrast, no PCR
product was obtained for the group 1 AT-encoding genes for any
of the strains. Most of the EHEC and EPEC strains returned a
positive result for ehaA, ehaB, and ehaC, indicating that these AT-
encoding genes are highly prevalent. The group 2/3 PCR product
was only amplified from EHEC strains (18%), while the group 4/5
PCR product was only amplified from EPEC strains (19%).
While the initial screening of the group 6/7 AT-encoding genes
was based on a conserved set of primers for both groups, further
screening with primers specific for the group 6 gene indicated that
this gene is present in 12/44 (27%) of EHEC and 2/20 (10%) of
EPEC strains.We focused the remainder of our study on this gene,
and in accordance with the terminology adopted for other AT-
encoding genes of EHEC (Wells et al., 2008), we have termed the
group 6 AT-encoding gene ehaJ.
Table 1 | Prevalence of AT-encoding genes in EHEC and EPEC.
Gene EHEC (n= 44) EPEC (n= 21a) AT typeb
ehaA 43 (97%) 18 (86%) AIDA-I
ehaB 41 (93%) 21 (100%) AIDA-I
ehaC 44 (100%) 21 (100%) AIDA-I
ehaD 5 (11%) 5 (24%) AIDA-I
Group 1 0 0 TAA
Group 2/3 8 (18%) 0 TAA
Group 4/5 0 4 (19%) TAA
Group 6/7 44 (100%) 21 (100%) AIDA-I
ehaJ 12 (27%) 3 (14%) AIDA-I
aIncluding bioinformatic screening of EPEC strain E2348/69.
bAutotransporter type as indicated byWells et al. (2010).
ehaJ LIES ADJACENT TO A PUTATIVE GLYCOSYLTRANSFERASE GENE
The EPEC strain 2348/69 is the only genome sequenced E. coli
strain in the NCBI database that contains the ehaJ gene (locus
tag E2348C_2704). Further investigation of the EPEC E2348/69
genome revealed the presence of a gene encoding a putative
glycosyltransferase immediately upstream of ehaJ (locus tag
E2348C_2705), which we have referred to as EhaJ glycosyltrans-
ferase or egtA (Figure 1). This tandem glycosyltransferase-AT gene
arrangement is similar to that observed for the AidA and TibA
AT proteins (Benz and Schmidt, 1989; Elsinghorst and Kopecko,
1992). EhaJ shares 26.1%amino acid identitywithAidAand22.7%
amino acid identity with TibA. Both the AidA and the TibA AT
genes are located immediately downstreamof a glycosyltransferase
encoding gene (Figure 1). The tib locus also contains two addi-
tional genes, tibD and tibB, which have been suggested to play a
role in regulation (Lindenthal and Elsinghorst, 1999). The pre-
dicted product of the egtA gene shares 63.9% amino acid identity
with theTibC glycosyltransferase fromETECH10407 (Elsinghorst
and Weitz, 1994) and 62.1% amino acid identity with the AIDA-
associated Aah heptosyltransferase from EPEC 2787 (Benz and
Schmidt, 1989, 1992).
THE ehaJ GENE ENCODES A PROTEIN THAT LOCALIZES TO THE CELL
SURFACE
In order to determine if EhaJ is glycosylated and if glycosyla-
tion affects EhaJ function, we constructed two different plasmids.
We selected one ehaJ -positive EPEC strain from our collection,
MS455,andPCRamplified and cloned the egtA–ehaJ fragment as a
transcriptional fusiondownstreamof the tightly regulated araBAD
promoter in pBAD/Myc-HisA, resulting in plasmid pOMS2. Sim-
ilarly, a plasmid containing the ehaJ gene alone was constructed
by PCR amplification and cloning of the ehaJ gene from MS455
into pBAD/Myc-HisA, resulting in plasmid pOMS3. Unlike the
AidA and Ag43 AT proteins, expression of EhaJ did not mediate
cell aggregation following growth of these recombinant strains in
LB or M9 broth. Furthermore, we found no evidence to indicate
FIGURE 1 | Genomic context of the group 6 autotransporter gene ehaJ
and its associated glycosyltransferase gene egtA in EPEC 2348/69
genome (NC_011601) in comparison with K-12 strain MG1655
(NC_000913), EPEC 2787 (GU810159), and ETEC H10497 (FN649414).
Whilst the arrangement of the glycosyltransferase upstream of the
autotransporter gene is conserved, the genomic positions of these two genes
are different in the four genomes. The figure was generated using Easyfig
(http://easyfig.sourceforge.net/; Sullivan et al., 2011) with amino acid
sequence comparison (tBLASTx). The level of amino acid identity is shown in
the gradient scale.
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that the passenger domain of EhaJ could be released from the cell
surface following brief heat treatment at 60˚C.
EhaJ IS GLYCOSYLATED IN THE PRESENCE OF THE egtA GENE PRODUCT
To demonstrate expression of the EhaJ protein, plasmids pOMS2
and pOMS3 were transformed into the previously described E.
coli K-12 flu mutant strain MS427, respectively. E. coli MS427 is
unable tomediate the classical cell aggregation and biofilm pheno-
types associated with Ag43 expression (Reisner et al., 2003). EhaJ
cell-surface expression was demonstrated by immunofluorescence
microscopy (Figure 2) using a rabbit polyclonal antiserum tar-
geting a region in the predicted N-terminal passenger domain
of EhaJ. Western blot analysis employing the same EhaJ-specific
antiserum detected a 155-kDa protein in whole cell lysates pre-
pared from E. coli MS427(pOMS2) following induction with
arabinose (Figure 2). When the same analysis was performed
on E. coli MS427(pOMS3), a smaller protein of approximately
110 kDa was detected using the EhaJ-specific serum. The differ-
ence in the size of EhaJ in the presence and absence of the egtA
gene provides evidence to suggest that EhaJ is glycosylated. Gly-
cosylation of EhaJ was demonstrated by staining of SDS-PAGE
separated proteins fromwhole cell lysates of MS427(pOMS2) with
the Glycoprofile III stain. Staining of the 155-kDa EhaJ protein
was only observed in the presence of EgtA (Figure 2). A lower
molecular weight band that also stained with Glycoprofile III was
also visible on this gel (only in the presence of EgtA); we sug-
gest that this band may represent a partially glycosylated version
of EhaJ.
EXPRESSION OF GLYCOSYLATED EhaJ MEDIATES BIOFILM FORMATION
To determine whether the EhaJ protein promotes biofilm for-
mation, we examined the effect of EhaJ over-expression in E.
coli MS427 in a static biofilm assay in a non-treated poly-
styrene microtiter plate model after growth in M9 minimal
medium (Figure 3A). MS427(pOMS2), which produces glyco-
sylated EhaJ, exhibited greatly enhanced biofilm production in
comparison to both the negative control strain, MS427(pBAD)
and the strain expressing EhaJ without the glycosyltransferase
[MS427(pOMS3)]. The ability of glycosylated EhaJ to promote
biofilm formation was further assessed by over-expression in E.
coli OS56 (a GFP-tagged derivative of MS427) in dynamic con-
ditions using the continuous flow chamber model, which permits
monitoring of the bacterial distributionwithin an evolving biofilm
at the single cell level due to the combination of GFP-tagged
cells and scanning confocal laser microscopy. Glycosylated EhaJ
[OS56(pOMS2)] promoted strong biofilm growth under these
conditions andproduced a structurewith adepthof approximately
10μm (Figure 3B).
EhaJ MEDIATES ADHERENCE TO EXTRACELLULAR MATRIX PROTEINS
To study the adhesive properties of EhaJ we examined its ability
to mediate binding to various cellular and extracellular targets.
Initially, we tested the ability of EhaJ to mediate adherence to
HeLa and Caco2 cells, however no binding was observed for E. coli
OS56(pOMS2-kan; data not shown). Next,we tested for the ability
of EhaJ to mediate adherence to MaxGel, a commercially avail-
able mixture of ECM components including collagens, laminin,
FIGURE 2 | (A)Western blotting with EhaJ-specific antiserum
demonstrates the difference in size of EhaJ from MS427(pOMS2) and
MS427(pOMS3). Molecular mass markers (M) are pre-stained Novex®
Sharp Standard (Invitrogen). (B) SDS-PAGE analysis demonstrating (i)
Coomassie blue staining and (ii) Glycoprofile III fluorescent staining of
proteins prepared from whole cell lysates of MS427(pOMS2) and
MS427(pOMS3). Staining of the 155-kDa EhaJ protein with Glycoprofile III
was only observed in the presence of EgtA. A lower molecular weight band
that also stained with Glycoprofile III and may represent a partially
glycosylated form of EhaJ was also observed in MS427(pOMS2). Although
this band is not visible on the western blot shown in (A), it was visible in
other western blots that were allowed to develop for a longer time period.
(C) Immunofluorescence microscopy demonstrating surface localization of
EhaJ. Phase-contrast (left) and fluorescence (right) images of MS427(pBAD;
top) and MS427(pOMS2; bottom). Strains were grown in the presence of
0.2% arabinose for all three panels. G-EhaJ indicates glycosylated EhaJ.
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FIGURE 3 | (A) Glycosylated EhaJ [MS427(pOMS2)] mediates enhanced
static biofilm formation in a microtiter plate assay at both 28˚C and 37˚C.
Results are expressed as the average of six technical replicates within each
plate; error bars indicate SD. These results are representative, confirmed by
three independent experiments. (B) Glycosylated EhaJ mediates enhanced
biofilm formation in a dynamic flow cell system at 28˚C. Spatial distribution
of dynamic biofilm formation by GFP-labeled E. coli strains
OS56(pBAD-kan) and E. coli OS56(pOMS2-kan) was monitored by confocal
scanning laser microscopy at 15 h (left) and 48 h (right) after inoculation.
Shown are representative horizontal sections collected within each biofilm
and vertical sections (to the right and below for each individual panel)
representing the yz-plane and the xz-plane, respectively, at the positions
indicated by the white lines.
fibronectin, tenascin, elastin, a number of proteoglycans, and
glycosaminoglycans. Both E. coli MS427(pOMS2) and E. coli
MS427(pOMS3) adhered equally well in this assay (Figure 4),
and thus we examined binding in more detail by testing a
range of different ECM proteins. E. coli MS427(pOMS2) and
E. coli MS427(pOMS3) adhered strongly to collagen I, collagen
II, collagen III, collagen V, fibronectin, fibrinogen, and laminin
(Figure 4).
CONSTRUCTION AND CHARACTERIZATION OF AN ehaJ MUTANT
Todeterminewhether EhaJ is expressed inwild-type EPECMS455,
we constructed an ehaJ deletion mutant employing λ-red medi-
ated homologous recombination of linear DNA (referred to as
MS455ehaJ ). Examination of whole cell lysates prepared from
MS455 and MS455ehaJ, following growth in LB broth, by SDS-
PAGE and western blotting demonstrated a low level of expression
of EhaJ in E. coli MS455 and an absence of EhaJ in MS455ehaJ
(Figure 5).We then tested MS455 and MS455ehaJ for their ability
to adhere to MaxGel. MS455 adhered poorly in this assay, and
although MS455ehaJ adhered less well, the difference was not
statistically significant. MS455ehaJ complemented with pOMS3
bound strongly to the MaxGel, consistent with results obtained
when EhaJ was expressed under control of the araBAD promoter
in the MS427 background (Figure 4 and data not shown). Similar
results were also obtained with regards to biofilm formation in
the microtiter plate assay (data not shown). Thus, while EhaJ is
a newly identified AT protein expressed by E. coli MS455, further
studies will be required to investigate the function of this protein
in wild-type strains.
DISCUSSION
Autotransporters are a diverse family of outer membrane pro-
teins that have various virulence-associated functions, including
in biofilm formation and adherence to mammalian cells. Our pre-
vious study of fourAT proteins identified in E. coli O157:H7 strain
EDL933, termed EhaA, EhaB, EhaC, and EhaD, assessed the preva-
lence of these genes in STEC strains (Wells et al., 2008). In the
present study, we have extended this analysis to include two strain
libraries from our collection that have been confirmed by both
serotyping and virulence gene analysis as EHEC or EPEC strains,
for comparison of prevalence between these two pathotypes. The
prevalence of the translocation (β) domain for each of these AT
genes in the EHEC collection was found to be similar in this study
to that found in our previous study (Wells et al., 2008) and also
similar to the prevalence in the EPEC collection (Table 1).
Our recent bioinformatic approach to the identification and
classification of AT proteins in E. coli revealed several predicted
AT genes that did not group with those previously characterized
and these were termed groups 1–7 (Wells et al., 2010). The present
study also sought to assess the prevalence of these newly identi-
fied AT genes in our EHEC and EPEC libraries. Groups 1, 2, and
3, which were all closely grouped with the TAA clade, were not
detected in our EPEC library in the current study. The group 1
gene was also not detected in the EHEC library and the group 2/3
screen only returned the correct PCR product in 18%of the EHEC
strains. Each of these genes was only found in one publically avail-
able genome sequence (Wells et al., 2010); the group 1 gene was
found in strain SMS 3–5, an environmental strain, and groups 2
and 3 were found in strain ED1a, originally isolated from a healthy
adult. Thus it was not unexpected that these apparently rare AT
genes would be absent from pathogenic strains. The group 4 gene
was originally identified in strain UMN26, a uropathogenic strain,
and the group 5 gene was identified in four strains, of differing
pathotypes, including EPEC strain E2348/69. The current study
indicated amodest prevalence of these genes (approximately 19%)
in EPEC strains and an absence in EHEC strains. We note that the
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FIGURE 4 | EhaJ mediates attachment to a range of ECM proteins in an
ELISA-based binding assay. MS427 bound to MaxGel, collagen I, II, III and V,
fibronectin, fibrinogen, and laminin when expressing ehaJ with or without
co-expression of egtA [* indicates significant difference (P < 0.05) in
comparison with BSA control]. EhaJ did not mediate adherence to collagen IV,
elastin, heparin sulfate, or BSA.
PCR-based approach we adopted does not distinguish between
the presence of intact genes and pseudogenes. Future studies may
address this issue and investigate the presence of these AT genes in
different pathotypes of E. coli.
Screening for the translocation domain of the group 6 and 7
genes indicated that at least one of these genes is present in all of
the strains tested in both the EHEC and EPEC libraries. However,
specific screening for the group 6 gene, now termed ehaJ, found
only a modest prevalence of this gene (15–27%), suggesting that
the group 7 gene may be highly prevalent. However, BLASTn and
BLASTp searches of E. coli genomes available through the NCBI
database indicated that the group 7 gene is truncated to only the
translocation domain, or parts of the translocation domain, in
the majority of strains, explaining why this gene was not iden-
tified in more strains in the original study. The group 7 gene
was found in only four strains previously, however the current
searches identify the full gene in 11 E. coli strains and four
Shigella flexneri strains. We chose to focus on the group 6 AT,
which we have termed EhaJ, as analysis of the genomic context
of the gene identified in EPEC strain E2348/69 (E2348C_2704)
revealed the presence of a predicted glycosyltransferase immedi-
ately upstream(E2348C_2705), termed egtA.As shown inFigure 1,
this is similar to the organization of the aah/aidA and tibC/tibA
systems. Comparison of egtA with these other AT-associated gly-
cosyltransferases revealed that egtA shares approximately 60%
identity, with tibC and aah. Glycosylation of AIDA-I by the
aidA-associated heptosyltransferase (AAH) is necessary forAIDA-
I-mediated adherence to mammalian cells (Benz and Schmidt,
2001; Charbonneau et al., 2007). However, Charbonneau et al.
(2007)also demonstrated that glycosylation is not necessary for
the cell-binding domain to bind Hep-2 cells, but that glycosyla-
tion greatly enhances stability and protease-resistance of AIDA-I.
They therefore suggest that glycosylation is needed for adher-
ence only indirectly, in that it likely stabilizes the conforma-
tion of the cell-binding domain. TibA was the first glycosylated
AT described in E. coli and a recent study has shown that its
glycosyltransferase, TibC, is functionally interchangeable with
AAH (Moormann et al., 2002). Both AIDA-I and TibA medi-
ate bacterial aggregation and biofilm formation through self-
association, but this function is independent of glycosylation
(Sherlock et al., 2004, 2005).
Some AT proteins exhibit functional redundancy, such that
deletion of individual AT genes often does not give rise to a
measurable phenotype. As such, we chose to investigate the pos-
sible function of EhaJ, and the potential role of glycosylation by
EgtA, in an E. coli MG1655flu strain, which is unable to mediate
the classical cell aggregation and biofilm phenotypes associated
with Ag43 expression (Reisner et al., 2003). Western blotting indi-
cated that both genes were expressed in this background and
that the EhaJ protein has a molecular mass of approximately
155 kDa on SDS-PAGE. However, the molecular mass of EhaJ
was approximately 110 kDa when expressed in the absence of
EgtA, suggesting that glycosylation of EhaJ is responsible for an
approximately 45 kDa shift and that the genes encoding these
two proteins are functional. Glycosylation of the 155-kDa pro-
tein was confirmed using the glycoprotein-specific Glycoprofile III
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FIGURE 5 | (A)Western blotting with rabbit antiserum specific for the
passenger domain of demonstrates expression of EhaJ in wild-type EPEC
strain MS455 and loss of EhaJ in MS455ehaJ. Molecular mass (kDa) for the
protein markers (M) [Novex Sharp Standards, Invitrogen] is shown on the
right. (B)Wild-type strain MS455 did not bind strongly to the MaxGel
protein mixture in an ECM binding assay and inactivation of EhaJ in strain
MS455ehaJ did not reduce binding to ECM proteins in this assay
(P = 0.55). However, over-expression of ehaJ (but not egtA) in
MS455ehaJ (pOMS3) lead to a small but reproducible increase in binding to
the MaxGel protein mixture (P = 0.008). An unpaired t -test was used for
statistical comparisons using GraphPad Prism 5.
stain. Additionally, immunofluorescence microscopy confirmed
that EhaJ was expressed on the bacterial surface.
Several AT proteins mediate cell aggregation and biofilm for-
mation independent of glycosylation, including Ag43, TibA, AidA
(Sherlock et al., 2006), and the recently described EhaA (Wells
et al., 2008). EhaJ differs from AIDA-I, TibC, and Ag43 in that
the passenger domain does not disassociate from the transloca-
tion domain following brief heat treatment and induction of EhaJ
expression in a K12flu background did not result in enhanced
bacterial aggregation or biofilm formation in the absence of EgtA-
mediated glycosylation.Most interestingly, EhaJ is able to promote
biofilm formation when co-expressed with EgtA, demonstrating
that this function is dependent upon glycosylation.
Further investigation of the function of EhaJ indicated that it
mediates adherence to several ECM proteins. The apparent speci-
ficity of EhaJ binding to collagen I, collagen II, collagen III, collagen
V, fibronectin, fibrinogen, and laminin is in line with studies on
some other AT proteins. For example, EhaB mediates adherence
to collagen I and laminin, but not collagen III, collagen IV or
fibronectin (Wells et al., 2009), and Tsh (from avian pathogenic
E. coli) mediates adherence to fibronectin and collagen IV, but not
laminin (Kostakioti and Stathopoulos, 2004). Thus, it is clear that
while many ATs bind a range of ECM proteins, the specificity of
eachATdiffers,which likely reflects or influences the tissue tropism
and pathogenicity of E. coli strains.We did not observe any signifi-
cant difference in the adherence pattern of E. coli MS427(pOMS2)
and E. coli MS427(pOMS3), suggesting that glycosylation of EhaJ
does not affect adherence to these ECM proteins. However, it
should be noted that small differences in adherencemay have been
masked by the over-expression of EhaJ, and thus differences may
become apparent at lower EhaJ expression levels. Analysis of bind-
ing of the wild-type MS455 strain to ECM proteins indicated that
this strain does not bind strongly to these proteins when grown
in LB broth and deletion of ehaJ did not significantly reduce the
level of binding. However, the strain was able to bind strongly
when ehaJ was over-expressed under control of the araBAD pro-
moter, suggesting that a low level of expression of ehaJ in the
wild-type strain may account for this difference. Studies into the
regulation of expression of ehaJ, and egtA, are therefore necessary
to determine the growth conditions under which these genes are
expressed to facilitate further functional studies.
Until relatively recently it was thought that only eukaryotic
species glycosylate proteins, however many bacterial species are
now known to possess N- and O-linked protein glycosylation sys-
tems (Nothaft and Szymanski, 2010). The targets of these systems
tend to be cell-surface structures such as pili and flagella, in addi-
tion toATproteins. EhaJ represents a newATprotein thatmediates
adherence to a set of specific extracellular matrix proteins and gly-
cosylation of EhaJ appears to be necessary for its ability to promote
biofilm formation. Future studies will explore the regulation of
ehaJ and egtA to determine the growth conditions under which
these genes are expressed and thus the potential significance of this
glycosylated AT protein to virulence.
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